Home › Companies › XERIS BIOPHARMA HOLDINGS INC. › 2023-2024
Compiled from SEC Form N-PX filings and XERIS BIOPHARMA HOLDINGS INC.’s Form 8-K, filed June 5, 2024 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of June 5, 2024: 6 items on XERIS BIOPHARMA HOLDINGS INC.’s Form 8-K, filed June 5, 2024: 6 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore XERIS BIOPHARMA HOLDINGS INC. in the interactive database Compare manager voting policies
These tallies are XERIS BIOPHARMA HOLDINGS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Paul R. Edick | 58,524,066 | -- | -- | 6,505,672 | 36,161,541 | 90% | Not verified | — |
| Elect Director: Ricki Fairley | 58,511,772 | -- | -- | 6,520,445 | 36,159,062 | 90% | Not verified | — |
| Elect Director: Marla S. Persky | 47,442,889 | -- | -- | 17,566,155 | 36,182,235 | 73% | Not verified | — |
| The Company's stockholders approved Proposal 2. The votes cast at the Annual Meeting were as follows*: | 99,452,328 | 807,990 | 930,961 | -- | -- | 99.1% | Not verified | — |
| The Company's stockholders approved Proposal 4. The votes cast at the Annual Meeting were as follows*: | 57,804,619 | 6,665,428 | 562,170 | -- | 36,159,062 | 90% | Not verified | — |
| The Company's stockholders approved Proposal 5. The votes cast at the Annual Meeting were as follows*: | 57,574,020 | 6,941,808 | 516,389 | -- | 36,159,062 | 89% | Not verified | — |
Source: XERIS BIOPHARMA HOLDINGS INC., Form 8-K, filed with the SEC on June 5, 2024 — read the filing on EDGAR.
Each item below shows how the 140 asset managers that disclosed a XERIS BIOPHARMA HOLDINGS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of XERIS BIOPHARMA HOLDINGS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
73% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Marla S. Persky
XERIS BIOPHARMA HOLDINGS INC.’s own tally for this item (“Elect Director: Marla S. Persky”): 47,442,889 for, 17,566,155 withheld, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 73% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 40 asset managers below reported 12,654,624 for, 4,793,779 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,347,475 | 0 | 0 | 33 | For |
| BlackRock | 0 | 0 | 0 | 3,597,833 | Withhold |
| Fidelity | 2,514,522 | 0 | 0 | 0 | For |
| TIAA | 1,194,477 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 555,605 | 0 | 0 | 0 | For |
| State Street | 452,788 | 0 | 0 | 606 | For |
| Charles Schwab | 366,293 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 324,647 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 259,973 | Withhold |
| Lincoln Financial | 113,800 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 73,974 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 65,577 | Withhold |
| Northern Trust | 59,679 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 53,938 | Withhold |
| John Hancock | 0 | 0 | 0 | 52,066 | Withhold |
| Pacific Life | 0 | 0 | 0 | 44,656 | Withhold |
| Voya | 0 | 0 | 0 | 44,099 | Withhold |
| Brighthouse | 0 | 0 | 0 | 43,863 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 35,697 | Withhold |
| Nationwide | 1,960 | 0 | 0 | 33,288 | Mixed |
| SEI | 29,100 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 0 | 0 | 24,029 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 21,932 | Withhold |
| AQR | 0 | 0 | 0 | 21,821 | Withhold |
| DWS | 0 | 0 | 0 | 20,745 | Withhold |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
Combines 2 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Paul R. Edick
XERIS BIOPHARMA HOLDINGS INC.’s own tally for this item (“Elect Director: Paul R. Edick”): 58,524,066 for, 6,505,672 withheld, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 40 asset managers below reported 17,430,065 for, 18,338 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,347,508 | 0 | 0 | 0 | For |
| BlackRock | 3,597,833 | 0 | 0 | 0 | For |
| Fidelity | 2,514,522 | 0 | 0 | 0 | For |
| TIAA | 1,194,477 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 555,605 | 0 | 0 | 0 | For |
| State Street | 453,362 | 0 | 0 | 32 | For |
| Charles Schwab | 366,293 | 0 | 0 | 0 | For |
| Equitable | 324,647 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 259,973 | 0 | 0 | 0 | For |
| Lincoln Financial | 113,800 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,974 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 65,577 | 0 | 0 | 0 | For |
| Northern Trust | 59,679 | 0 | 0 | 0 | For |
| ProShares | 53,938 | 0 | 0 | 0 | For |
| John Hancock | 52,066 | 0 | 0 | 0 | For |
| Pacific Life | 44,656 | 0 | 0 | 0 | For |
| Voya | 44,099 | 0 | 0 | 0 | For |
| Brighthouse | 43,863 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,697 | 0 | 0 | 0 | For |
| Nationwide | 35,248 | 0 | 0 | 0 | For |
| SEI | 29,100 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,029 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 21,932 | 0 | 0 | 0 | For |
| AQR | 21,821 | 0 | 0 | 0 | For |
| DWS | 20,745 | 0 | 0 | 0 | For |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
Combines 2 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Ricki Fairley
XERIS BIOPHARMA HOLDINGS INC.’s own tally for this item (“Elect Director: Ricki Fairley”): 58,511,772 for, 6,520,445 withheld, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 40 asset managers below reported 17,330,827 for, 117,576 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,347,508 | 0 | 0 | 0 | For |
| BlackRock | 3,597,833 | 0 | 0 | 0 | For |
| Fidelity | 2,514,522 | 0 | 0 | 0 | For |
| TIAA | 1,194,477 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 555,605 | 0 | 0 | 0 | For |
| State Street | 453,394 | 0 | 0 | 0 | For |
| Charles Schwab | 366,293 | 0 | 0 | 0 | For |
| Equitable | 225,377 | 0 | 0 | 99,270 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 259,973 | 0 | 0 | 0 | For |
| Lincoln Financial | 113,800 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,974 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 65,577 | 0 | 0 | 0 | For |
| Northern Trust | 59,679 | 0 | 0 | 0 | For |
| ProShares | 53,938 | 0 | 0 | 0 | For |
| John Hancock | 52,066 | 0 | 0 | 0 | For |
| Pacific Life | 44,656 | 0 | 0 | 0 | For |
| Voya | 44,099 | 0 | 0 | 0 | For |
| Brighthouse | 43,863 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,697 | 0 | 0 | 0 | For |
| Nationwide | 35,248 | 0 | 0 | 0 | For |
| SEI | 29,100 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,029 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 21,932 | 0 | 0 | 0 | For |
| AQR | 21,821 | 0 | 0 | 0 | For |
| DWS | 20,745 | 0 | 0 | 0 | For |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
100% of fund votes cast · no official result
Description as filed by funds: To approve an amendment to the Xeris Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan, to (i) remove the "evergreen" provision which provides for annual increases in the aggregate number of shares available for issuance thereunder and (ii) increase the aggregate number of shares available for issuance thereunder by 6,636,632 additional shares.
The 36 asset managers below reported 17,370,064 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,347,508 | 0 | 0 | 0 | For |
| BlackRock | 3,597,833 | 0 | 0 | 0 | For |
| Fidelity | 2,514,522 | 0 | 0 | 0 | For |
| TIAA | 1,194,477 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 555,605 | 0 | 0 | 0 | For |
| State Street | 453,394 | 0 | 0 | 0 | For |
| Charles Schwab | 366,293 | 0 | 0 | 0 | For |
| Equitable | 324,647 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 259,973 | 0 | 0 | 0 | For |
| Lincoln Financial | 113,800 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,974 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 65,577 | 0 | 0 | 0 | For |
| Northern Trust | 59,679 | 0 | 0 | 0 | For |
| ProShares | 53,938 | 0 | 0 | 0 | For |
| Pacific Life | 44,656 | 0 | 0 | 0 | For |
| Voya | 44,099 | 0 | 0 | 0 | For |
| Brighthouse | 43,863 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,697 | 0 | 0 | 0 | For |
| Nationwide | 35,248 | 0 | 0 | 0 | For |
| SEI | 29,100 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 21,932 | 0 | 0 | 0 | For |
| AQR | 21,821 | 0 | 0 | 0 | For |
| DWS | 20,745 | 0 | 0 | 0 | For |
| Principal | 17,868 | 0 | 0 | 0 | For |
| Victory Capital | 17,355 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.
Combines 4 wordings of this item as funds reported it.
98% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,347,508 | 0 | 0 | 0 | For |
| BlackRock | 3,597,833 | 0 | 0 | 0 | For |
| Fidelity | 2,514,522 | 0 | 0 | 0 | For |
| TIAA | 1,194,477 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 555,605 | 0 | 0 | 0 | For |
| State Street | 453,342 | 52 | 0 | 0 | For |
| Charles Schwab | 366,293 | 0 | 0 | 0 | For |
| Equitable | 324,647 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 259,973 | 0 | 0 | 0 | For |
| Lincoln Financial | 113,800 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,974 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 65,577 | 0 | 0 | 0 | For |
| Northern Trust | 59,679 | 0 | 0 | 0 | For |
| ProShares | 53,938 | 0 | 0 | 0 | For |
| John Hancock | 52,066 | 0 | 0 | 0 | For |
| Pacific Life | 44,656 | 0 | 0 | 0 | For |
| Voya | 44,099 | 0 | 0 | 0 | For |
| Brighthouse | 43,863 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,697 | 0 | 0 | 0 | For |
| Nationwide | 35,248 | 0 | 0 | 0 | For |
| SEI | 29,100 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,029 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 21,932 | 0 | 0 | 0 | For |
| AQR | 21,821 | 0 | 0 | 0 | For |
| DWS | 20,745 | 0 | 0 | 0 | For |
Fund voting reports, all 40 managers: 17,433,777 for, 14,626 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MPM BioImpact LLC | 4,224,380 | 0 | 0 | 0 | For |
| BlackRock | 3,028,065 | 15,460 | 0 | 0 | For |
| State Street | 3,003,333 | 937 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,710,536 | 0 | 0 | 0 | For |
| Nuveen | 1,199,882 | 0 | 0 | 0 | For |
| Northern Trust | 1,072,783 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 1,046,587 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 900,000 | 0 | 0 | 0 | For |
| AQR | 621,590 | 0 | 0 | 0 | For |
| Knott David M Jr | 600,000 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 597,478 | 0 | 0 | Against |
| Invenomic Capital Management LP | 580,580 | 0 | 0 | 0 | For |
| Lazard | 430,489 | 0 | 0 | 0 | For |
| Charles Schwab | 366,293 | 0 | 0 | 0 | For |
| Wellington | 355,857 | 0 | 0 | 0 | For |
| Vanguard | 275,203 | 0 | 0 | 0 | For |
| THOMPSON SIEGEL & WALMSLEY LLC | 191,250 | 0 | 0 | 0 | For |
| BROWN ADVISORY INC | 190,255 | 0 | 0 | 0 | For |
| Diversified Trust Co | 175,739 | 0 | 0 | 0 | For |
| Rubric Capital Management LP | 175,101 | 0 | 0 | 0 | For |
| Man Group plc | 154,648 | 0 | 0 | 0 | For |
| AMERIPRISE FINANCIAL INC | 144,306 | 0 | 0 | 0 | For |
| Rhumbline | 66,731 | 110 | 0 | 0 | For |
| JPMorgan | 101,451 | 0 | 0 | 0 | For |
| AllianceBernstein | 99,270 | 0 | 0 | 0 | For |
Institutional-manager reports, all 113 managers: 23,150,012 for, 712,502 against, 34,538 abstained, 20,000 not voted, 66,841 1 year. Showing the 25 largest; see all in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.8% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To indicate, on a non-binding advisory basis, the preferred frequency of future stockholder advisory votes on the compensation of our named executive officers.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| NORTHERN LIGHTS FUND TRUST II | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| Brighthouse | 0 | 0 | 0 | 0 | -- |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 0 | -- |
| AQR | 0 | 0 | 0 | 0 | -- |
| DWS | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 40 managers: 17,430,097 1 year, 18,306 3 year. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MPM BioImpact LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Redmile Group, LLC | 0 | 0 | 0 | 0 | -- |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 0 | 0 | 0 | -- |
| AQR | 0 | 0 | 0 | 0 | -- |
| Knott David M Jr | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| Invenomic Capital Management LP | 0 | 0 | 0 | 0 | -- |
| Lazard | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| Wellington | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| THOMPSON SIEGEL & WALMSLEY LLC | 0 | 0 | 0 | 0 | -- |
| BROWN ADVISORY INC | 0 | 0 | 0 | 0 | -- |
| Diversified Trust Co | 0 | 0 | 0 | 0 | -- |
| Rubric Capital Management LP | 0 | 0 | 0 | 0 | -- |
| Man Group plc | 0 | 0 | 0 | 0 | -- |
| AMERIPRISE FINANCIAL INC | 0 | 0 | 0 | 0 | -- |
| Rhumbline | 66,731 | 110 | 0 | 0 | For |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 112 managers: 66,731 for, 110 against, 20,000 not voted, 23,846,903 1 year, 25,000 2 year, 13,969 3 year. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2024.
The 40 asset managers below reported 17,448,403 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,347,508 | 0 | 0 | 0 | For |
| BlackRock | 3,597,833 | 0 | 0 | 0 | For |
| Fidelity | 2,514,522 | 0 | 0 | 0 | For |
| TIAA | 1,194,477 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 555,605 | 0 | 0 | 0 | For |
| State Street | 453,394 | 0 | 0 | 0 | For |
| Charles Schwab | 366,293 | 0 | 0 | 0 | For |
| Equitable | 324,647 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 259,973 | 0 | 0 | 0 | For |
| Lincoln Financial | 113,800 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 73,974 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 65,577 | 0 | 0 | 0 | For |
| Northern Trust | 59,679 | 0 | 0 | 0 | For |
| ProShares | 53,938 | 0 | 0 | 0 | For |
| John Hancock | 52,066 | 0 | 0 | 0 | For |
| Pacific Life | 44,656 | 0 | 0 | 0 | For |
| Voya | 44,099 | 0 | 0 | 0 | For |
| Brighthouse | 43,863 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 35,697 | 0 | 0 | 0 | For |
| Nationwide | 35,248 | 0 | 0 | 0 | For |
| SEI | 29,100 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,029 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 21,932 | 0 | 0 | 0 | For |
| AQR | 21,821 | 0 | 0 | 0 | For |
| DWS | 20,745 | 0 | 0 | 0 | For |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
Not shown here: this season’s fund filings also report 1 item from the meeting of June 4, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 148,224,403 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.96% |
| 2 | BlackRock | 2.43% |
| 3 | Fidelity | 1.70% |
| 4 | TIAA | 0.81% |
| 5 | NORTHERN LIGHTS FUND TRUST II | 0.37% |
| 6 | State Street | 0.31% |
| 7 | Charles Schwab | 0.25% |
| 8 | Equitable | 0.22% |
| 9 | QUANTITATIVE MASTER SERIES LLC | 0.18% |
| 10 | Lincoln Financial | 0.08% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | MPM BioImpact LLC | 2.85% |
| 2 | BlackRock | 2.05% |
| 3 | State Street | 2.03% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 1.83% |
| 5 | Nuveen | 0.81% |
| 6 | Northern Trust | 0.72% |
| 7 | Redmile Group, LLC | 0.71% |
| 8 | PNC BANK, NATIONAL ASSOCIATION | 0.61% |
| 9 | AQR | 0.42% |
| 10 | Knott David M Jr | 0.40% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 8.05% | 13F |
| Vanguard Group | 6.63% | 13F |
| Morgan Stanley | 2.17% | 13F |
| State Street | 2.17% | 13F |
| Geode Capital | 2.05% | 13F |
| Goldman Sachs | 1.21% | 13F |
| Millennium Management | 1.14% | 13F |
| Nuveen | 1.07% | 13F |
| Northern Trust | 0.78% | 13F |
| AQR Capital | 0.77% | 13F |
Percentages above are of 148,224,403 shares outstanding, as reported by XERIS BIOPHARMA HOLDINGS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from XERIS BIOPHARMA HOLDINGS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At XERIS BIOPHARMA HOLDINGS INC.'s shareholder meeting held June 5, 2024, in the 2023-2024 proxy season, 140 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,065 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. XERIS BIOPHARMA HOLDINGS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on a non-binding advisory basis, the compensation of our named executive officers. — the reporting funds and managers cast 98% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
XERIS BIOPHARMA HOLDINGS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.